Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy - A case report

Journal of Translational Medicine

Volumn 7, Issue , 2009, Pages

  Milani, Valeria ^a,b   Stangl, Stefan ^c   Issels, Rolf ^a,b   Gehrmann, Mathias ^c   Wagner, Beate ^a   Hube, Kathrin ^c   Mayr, Doris ^a   Hiddemann, Wolfgang ^a,d   Molls, Michael ^c   Multhoff, Gabriele ^b,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPIRUBICIN; GEMCITABINE; HEAT SHOCK PROTEIN 70; INTERLEUKIN 2; IRINOTECAN; OXALIPLATIN; CD56 ANTIGEN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY D;

ADOPTIVE TRANSFER; ADULT; ANASTOMOSIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CASE REPORT; CELL STRAIN K 562; CELL THERAPY; CHEMOEMBOLIZATION; COLON CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LEUKAPHERESIS; LIVER METASTASIS; LYMPHOCYTE SUBPOPULATION; MALE; MULTIPLE CYCLE TREATMENT; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; SURVIVAL TIME; T LYMPHOCYTE ACTIVATION; TREATMENT DURATION; TREATMENT REFUSAL; TREATMENT RESPONSE; ADENOCARCINOMA; AGED; CASE CONTROL STUDY; CLINICAL TRIAL (TOPIC); COLON TUMOR; FATALITY; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; TUMOR CELL LINE;

ADENOCARCINOMA; ADOPTIVE TRANSFER; AGED; ANTIGENS, CD56; CASE-CONTROL STUDIES; CELL LINE, TUMOR; CLINICAL TRIALS AS TOPIC; COLONIC NEOPLASMS; FATAL OUTCOME; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; INFUSIONS, INTRAVENOUS; INTERLEUKIN-2; K562 CELLS; KILLER CELLS, NATURAL; LEUKAPHERESIS; MALE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY D;

EID: 68349100013     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-7-50     Document Type: Article

References (41)

1. Dunn GP Old LJ Schreiber RD The immunobiology of cancer immunosurveillance and immunoediting Immunity 2004, 21:137-148. 10.1016/ j.immuni.2004.07.017 15308095
2. Gross C Hansch D Gastpar R Multhoff G Interaction of heat shock protein 70 peptide with NK cells involves the NK receptor CD94 Biol Chem 2003, 384:267-279. 10.1515/BC.2003.030 12675520
3. Gross C Schmidt-Wolf IG Nagaraj S Gastpar R Ellwart J Kunz-Schughart LA Multhoff G Heat shock protein 70-reactivity is associated with increased cell surface density of CD94/CD56 on primary natural killer cells Cell Stress Chaperones 2003, 8:348-360. 514906 15115287 10.1379/ 1466-1268(2003)008<0348:HSPRIA>2.0.CO;2
4. Gehrmann M Liebisch G Schmitz G Anderson R Steinem C De MA Pockley G Multhoff G Tumor-specific Hsp70 plasma membrane localization is enabled by the glycosphingolipid Gb3 PLoS ONE 2008, 3:e1925. 2271151 18382692 10.1371/journal.pone.0001925
5. Multhoff G Pfister K Gehrmann M Hantschel M Gross C Hafner M Hiddemann W A 14-mer Hsp70 peptide stimulates natural killer (NK) cell activity Cell Stress Chaperones 2001, 6:337-344. 434416 11795470 10.1379/ 1466-1268(2001)006<0337:AMHPSN>2.0.CO;2
6. Multhoff G Botzler C Issels R The role of heat shock proteins in the stimulation of an immune response Biol Chem 1998, 379:295-300. 9563825
7. Gastpar R Gehrmann M Bausero MA Asea A Gross C Schroeder JA Multhoff G Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells Cancer Res 2005, 65:5238-5247. 1785299 15958569 10.1158/0008-5472.CAN-04-3804
8. Zhang H Liu R Huang W A 14-mer peptide from HSP70 protein is the critical epitope which enhances NK activity against tumor cells in vivo Immunol Invest 2007, 36:233-246. 10.1080/08820130600992073 17558707
9. Multhoff G Botzler C Jennen L Schmidt J Ellwart J Issels R Heat shock protein 72 on tumor cells: A recognition structure for natural killer cells J Immunol 1997, 158:4341-4350. 9126997
10. Stangl S Wortmann A Guertler U Multhoff G Control of metastasized pancreatic carcinomas in SCID/beige mice with human IL-2/TKD-activated NK cells J Immunol 2006, 176:6270-6276. 16670338
11. Moser C Schmidbauer C Gurtler U Gross C Gehrmann M Thonigs G Pfister K Multhoff G Inhibition of tumor growth in mice with severe combined immunodeficiency is mediated by heat shock protein 70 (Hsp70)-peptide-activated, CD94 positive natural killer cells Cell Stress Chaperones 2002, 7:365-373. 514836 12653481 10.1379/ 1466-1268(2002)007<0365:IOTGIM>2.0.CO;2
12. Gross C Holler E Stangl S Dickinson A Pockley AG Asea AA Mallappa N Multhoff G An Hsp70 peptide initiates NK cell killing of leukemic blasts after stem cell transplantation Leuk Res 2008, 32:527-534. 10.1016/ j.leukres.2007.03.027 17543383
13. Gross C Koelch W DeMaio A Arispe N Multhoff G Cell surface-bound heat shock protein 70 (Hsp70) mediates perforin-independent apoptosis by specific binding and uptake of granzyme B J Biol Chem 2003, 278:41173-41181. 10.1074/jbc.M302644200 12874291
14. Pfister K Radons J Busch R Tidball JG Pfeifer M Freitag L Feldmann HJ Milani V Issels R Multhoff G Patient survival by Hsp70 membrane phenotype: Association with different routes of metastasis Cancer 2007, 110:926-935. 10.1002/cncr.22864 17580361
15. Krause SW Gastpar R Andreesen R Gross C Ullrich H Thonigs G Pfister K Multhoff G Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: A clinical phase I trial Clin Cancer Res 2004, 10:3699-36707. 10.1158/ 1078-0432.CCR-03-0683 15173076
16. Macdonald JS Adjuvant therapy of colon cancer Cancer J Clin 1999, 49:202-219. 10.3322/canjclin.49.4.202
17. O'Connell JB Maggard MA Ko CY Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging J Natl Cancer Inst 2004, 96:1420-1425. 15467030
18. Multhoff G Mizzen L Winchester CC Milner CM Wenk S Eissner G Kampinga HH Laumbacher B Johnson J Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells Exp Hematol 1999, 27:1627-1636. 10.1016/S0301-472X(99)00104-6 10560910
19. Multhoff G Pfister K Botzler C Jordan A Scholz R Schmetzer H Burgstahler R Hiddemann W Adoptive transfer of human natural killer cells in mice with severe combined immunodeficiency inhibits growth of Hsp70-expressing tumors Int J Cancer 2000, 88:791-797. 10.1002/ 1097-0215(20001201)88:5<791::AID-IJC17>3.0.CO;2-I 11072250
20. Stangl S Gross C Pockley AG Asea AA Multhoff G Influence of Hsp70 and HLA-E on the killing of leukemic blasts by cytokine/Hsp70 peptide-activated human natural killer (NK) cells Cell Stress Chaperones 2008, 13:221-230. 2673894 18759005 10.1007/s12192-007-0008-y
21. Diederichsen AC Hjelmborg JB Christensen PB Zeuthen J Fenger C Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells Cancer Immunol Immunother 2003, 52:423-428. 10.1007/s00262-003-0388-5 12695859
22. Naito Y Saito K Shiiba K Ohuchi A Saigenji K Nagura H Ohtani H CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer Cancer Res 1998, 58:3491-3494. 9721846
23. Pages F Berger A Camus M Sanchez-Cabo F Costes A Molidor R Mlecnik B Kirilovsky A Nilsson M Damotte D Meatchi T Bruneval P Cugnenc PH Trajanoski Z Fridman WH Galon J Effector memory T cells, early metastasis, and survival in colorectal cancer N Engl J Med 2005, 353:2654-2666. 10.1056/NEJMoa051424 16371631
24. Galon J Costes A Sanchez-Cabo F Kirilovsky A Mlecnik B Lagorce-Pages C Tosolini M Camus M Berger A Wind P Zinzindohoue F Bruneval P Cugnenc PH Trajanoski Z Fridman WH Pages F Type, density, and location of immune cells within human colorectal tumors predict clinical outcome Science 2006, 313:1960-1964. 10.1126/science.1129139 17008531
25. Elsner L Muppala V Gehrmann M Lozano J Malzahn D Bickeboller H Brunner E Zientkowska M Herrmann T Walter L Alves F Multhoff G Dressel R The heat shock protein Hsp70 promotes mouse NK cell activity against tumors that express inducible NKG2D ligands J Immunol 2007, 179:5523-5533. 17911639
26. O'Connell MJ Campbell ME Goldberg RM Grothey A Seitz JF Benedetti JK Andre T Haller DG Sargent DJ Survival following recurrence in stage II and III colon cancer: Findings from the ACCENT data set J Clin Oncol 2008, 26:2336-2341. 10.1200/JCO.2007.15.8261 18467725
27. Stangl R Tendorf-Hofmann A Charnley RM Scheele J Factors influencing the natural history of colorectal liver metastases Lancet 1994, 343:1405-1410. 10.1016/S0140-6736(94)92529-1 7515134
28. Schrag D The price tag on progress - chemotherapy for colorectal cancer N Engl J Med 2004, 351:317-319. 10.1056/NEJMp048143 15269308
29. Erlichman C Sargent DJ New treatment options for colorectal cancer N Engl J Med 2004, 351:391-392. 10.1056/NEJMe048151 15269321
30. Chan R Kerr D Hepatic arterial chemotherapy for colorectal cancer liver metastases: A review of advances in 2003 Curr Opin Oncol 2004, 16:378-384. 10.1097/01.cco.0000126577.04727.e9 15187894
31. Tellez C Benson AB III Lyster MT Talamonti M Shaw J Braun MA Nemcek AA Jr Vogelzang RL Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature Cancer 1998, 82:1250-1259. 10.1002/ (SICI)1097-0142(19980401)82:7<1250::AID-CNCR7>3.0.CO;2-J 9529016
32. Greene FL Stewart AK Norton HJ A new TNM staging strategy for node-positive (stage III) colon cancer: An analysis of 50,042 patients Ann Surg 2002, 236:416-421. 1422595 12368669 10.1097/ 00000658-200210000-00003
33. Gill S Loprinzi CL Sargent DJ Thome SD Alberts SR Haller DG Benedetti J Francini G Shepherd LE Francois SJ Labianca R Chen W Cha SS Heldebrant MP Goldberg RM Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: Who benefits and by how much? J Clin Oncol 2004, 22:1797-1806. 10.1200/JCO.2004.09.059 15067028
34. Tesniere A Apetoh L Ghiringhelli F Joza N Panaretakis T Kepp O Schlemmer F Zitvogel L Kroemer G Immunogenic cancer cell death: A key-lock paradigm Curr Opin Immunol 2008, 20:504-511. 10.1016/j.coi.2008.05.007 18573340
35. Lindquist S Craig EA The heat-shock proteins Annu Rev Genet 1988, 22:631-677. 10.1146/annurev.ge.22.120188.003215 2853609
36. Morimoto RI Kline MP Bimston DN Cotto JJ The heat-shock response: regulation and function of heat-shock proteins and molecular chaperones Essays Biochem 1997, 32:17-29. 9493008
37. Botzler C Ellwart J Gunther W Eissner G Multhoff G Synergistic effects of heat and ET-18-OCH3 on membrane expression of hsp70 and lysis of leukemic K562 cells Exp Hematol 1999, 27:470-478. 10.1016/ S0301-472X(98)00055-1 10089909
38. Multhoff G Meier T Botzler C Wiesnet M Allenbacher A Wilmanns W Issels RD Differential effects of ifosfamide on the capacity of cytotoxic T lymphocytes and natural killer cells to lyse their target cells correlate with intracellular glutathione levels Blood 1995, 85:2124-2131. 7718883
39. Ulbrecht M Martinozzi S Grzeschik M Hengel H Ellwart JW Pla M Weiss EH Cutting edge: The human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis J Immunol 2000, 164:5019-5022. 10799855
40. Njemini R Demanet C Mets T Comparison of two ELISAs for the determination of Hsp70 in serum J Immunol Meth 2005, 306:176-182. 10.1016/j.jim.2005.08.012
41. Yeh CH Tseng R Zhang Z Cortes J O'Brien S Giles F Hannah A Estrov Z Keating M Kantarjian H Albitar M Circulating Hsp70 and progression in patients with chronic myeloid leukemia Leuk Res 2009, 33:212-217. 10.1016/j.leukres.2008.07.012 18715642